COVID-19 | CHQ-GDL- 63327 - The management and treatment of children with acute SARS-CoV-2 infection (COVID-19) [PDF 1147.64 KB] |
COVID-19 | CHQ-GDL-63400 - Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS and MIS-C) [PDF 264.2 KB] |
COVID-19 | Drug interactions with COVID-19 therapies – Liverpool COVID-19 interactions on the University of Liverpool website |
COVID-19 | Queensland statewide COVID-19 guidelines on the Queensland Health website |
Antimicrobial allergies | CHQ-GDL-60011 - Allergic reaction emergency management in children and management of acute anaphylaxis [PDF 570.34 KB] – guideline and flow chart |
Antimicrobial allergies | CHQ-GDL-01076 – Paediatric antibiotic allergy assessment, testing and de-labelling [PDF 924.33 KB] |
Antimicrobial allergies | ASCIA medication allergy – Health care professional resources on the Australasian Society of Clinical Immunology and Allergy website website |
Cardiac infections | CHQ-GDL-01202 - Endocarditis [PDF 724.18 KB] |
Cardiac infections | CHQ-GDL-01202 - Endocarditis – Prosthetic valve, nosocomial infection or community acquired MRSA is suspected [PDF 724.18 KB] |
Cardiac infections | CHQ-GDL-01066 - Deep cardiac surgical wound infection – mediastinitis suspected [PDF 563.28 KB] |
Cardiac infections | CHQ-GDL-01066 - Post cardiac surgery (within 72 hours of surgery) – Suspicion of infection without a focus [PDF 563.28 KB] |
Cardiac infections | CHQ-GDL-01066 - Post cardiac surgery – CVAD associated or bloodstream infection focus [PDF 563.28 KB] |
Cardiac infections | CHQ-GDL-01066 - Post cardiac surgery with respiratory focus [PDF 563.28 KB] |
Cardiac infections | Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition) on the RHD Australia website |
Refugee health | ASID diagnosis, management and prevention of infections in recently arrived refugees 2016 (abridged version) on the Medical Journal of Australia website |
Parasitic infections | Acanthamoeba (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Amoebiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Amoebic meningoencephalitis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ancylostoma caninum (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ancylostoma duodenale (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Angiostrongyliasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Anisakiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ascariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Babesiosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Balamuthia mandrillaris (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Balantidiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Baylisascariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Blastocystis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Capilliaris (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Chaga's disease (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Clonorchis sinensis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cryptosporiodosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cutaneous Larva Migrans (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cyclosporiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Dientamoeba fragilis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Diphyllobothrium latum (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Dracunculus medinensis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Echinococcus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Entamoeba hystolytica (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Fasciola hepatica (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Filariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Fluke, hermaphrodytic infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Hookworm infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Hydatid disease (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Leishmaniasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Lice infestation (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Loa loa (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Microsporiodosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Naeglaria species (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Necator americanus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Onchocerca volvulus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | River blindness (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Roundworm (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Scabies (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Schistosomiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Sleeping sickness (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Strongyloidiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Tapeworm infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Toxocariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Toxoplasmosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trichinellosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trichomoniasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trypanosomiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Whipworm (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | CHQ-GDL-01219 - Snail and slug ingestion – Prophylaxis against Angiostrongylus cantonensis (rat lung worm) infection [PDF 170.28 KB] |
Parasitic infections | CHQ-GDL-63401 - Strongyloides and immunosuppressed Children: Screening, management and prophylaxis for Queensland Health staff on the intranet |
Perinatal and congenital infections | ASID Congenital CMV disease – Treatment and management on the ASID SharePoint website |
Perinatal and congenital infections | CHQ-GDL-01005 - Congenital CMV [PDF 388.82 KB] |
Perinatal and congenital infections | ASID management of perinatal infection – Consensus guideline 2014 on the ASID SharePoint website |
Perinatal and congenital infections | Enterovirus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Hepatitis B virus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Hepatitis C virus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Human immunodeficiency virus (HIV) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Mycobacterium tuberculosis – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Parvovirus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Rubella (German measles) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Streptococcus Group B – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Syphilis in pregnancy (Queensland Health guideline) |
Perinatal and congenital infections | Toxoplasma gondii – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Listeria – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Varicella zoster virus (VZV) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Herpes simplex virus (HSV) – ASID management of perinatal infections on the ASID SharePoint website |
|
CNS infections
| CHQ-GDL-60818 - Infectious encephalitis: investigation & initial management for Queensland Health staff on the intranet |
CNS infections | CHQ-GDL-01202 - Meningitis (less than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Meningitis (less than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Suspected encephalitis (less than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Suspected encephalitis (less than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Meningitis (more than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Meningitis (more than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Suspected encephalitis (more than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Suspected encephalitis (more than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-60008 - Meningitis – emergency management guideline |
CNS infections | CHQ-WI-00147 – Audiological monitoring of patients with a history of infection related to hearing loss for Queensland Health staff on the intranet |
CNS infections | CHQ-GDL-01202 - Prophylaxis for neisseria meningitidis (meningococcus)
[PDF 724.18 KB] |
CNS infections | Intraventricular dosing of antibiotics – IDSA bacterial meningitis guideline on the Infectious Diseases Society of America website |
CNS infections | Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand on the Wiley website |
CNS infections | Clinical practice guidelines for healthcare-associated ventriculitis and meningitis 2017 on the Infectious Diseases Society of America website |
CNS infections | CHQ-GDL-01202 - VP (CSF) Shunt infection [PDF 724.18 KB] |
ENT infections | CHQ-GDL-01202 - Acute otitis media [PDF 724.18 KB] |
ENT infections | CHQ-GDL-60000 - Acute otitis media – Emergency management guideline |
ENT infections | CHQ-GDL-02801 - Management of Post-Tonsillectomy Haemorrhage for Queensland Health staff on the intranet |
ENT infections | CHQ-GDL-00720 - Otitis externa – Emergency management in children [PDF 287.53 KB] |
ENT infections | CHQ-GDL-01202 - Mastoiditis [PDF 724.18 KB] |
ENT infections | CHQ-GDL-01202 - Retropharyngeal abscess [PDF 724.18 KB] |
ENT infections | CHQ-GDL-01202 - Tonsillitis [PDF 724.18 KB] |
Eye infections | CHQ-GDL-01074 – Acute management of open globe injuries (penetrating eye injury, ophthalmic, eye infections or keratitis) [PDF 317.58 KB] |
Eye infections | CHQ-GDL-63331 - Neonatal Conjunctivitis: Emergency Management for Queensland Health staff on the intranet |
Gastro-intestinal infections | CHQ-GDL-01202 - Appendicitis – no perforation (uncomplicated) [PDF 724.18 KB] |
Gastro-intestinal infections | CHQ-GDL-01202 - Appendicitis – perforation, appendiceal collection or abscess (complicated) [PDF 724.18 KB] |
Gastro-intestinal infections | CHQ-GDL-01202 - Necrotising enterocolitis [PDF 724.18 KB] |
Gastro-intestinal infections | CHQ-GDL-01202 - Peritonitis [PDF 724.18 KB] |
Gastro-intestinal infections | CHQ-GDL-01066 - Abdominal infection and peritonitis – PICU |
Gastro-intestinal infections | Peritonitis in a paediatric peritoneal dialysis (CAPD) patient on the Queensland Health website |
Gastro-intestinal infections | CHQ-GDL-01202 - Cholangitis [PDF 724.18 KB] |
Gastro-intestinal infections | ASID updated guidelines for the management of clostridium difficile infection in adults and children in Australia and New Zealand on the Wiley website |
Gastro-intestinal infections | CHQ-GDL-01058 - Clostridium difficile (C.difficile) infection [PDF 326.75 KB] |
Gastro-intestinal infections | CHQ-GDL-63001 - Non-typhoidal salmonellosis in children – management guideline
[PDF 239.91 KB] |
Gastro-intestinal infections | CHQ-GDL-01202 - Pinworms [PDF 724.18 KB] |
Gastro-intestinal infections | CHQ-GDL-01202 - Giardiasis [PDF 724.18 KB] |
Hospital In the Home (HITH) | Cystic fibrosis pulmonary exacerbation [PDF 613.07 KB] |
Hospital In the Home (HITH) | Non CF bronchiectasis pulmonary exacerbation – QCH HITH ED pathway [PDF 458.54 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Cellulitis – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Pre-septal or peri-orbital cellulitis – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Community acquired pneumonia – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Lymphadenitis – QCH HITH ED pathway
[PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Urinary tract infections – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | Suitability of parenteral antimicrobials for HITH use |
Respiratory infections | Paediatric influenza and oseltamivir clinical guideline – Paediatric Improvement Collaborative on the Royal Children's Hospital Melbourne website |
Respiratory infections | Clinical practice guidelines by the Infectious Diseases Society of America: 2018 Update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza on the National Library of Medicine website |
Respiratory infections | CHQ-GDL-60012 - Bronchiolitis [PDF 629.5 KB] |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (less than 1 month of age) [PDF 724.18 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-00759 – Community acquired pneumonia (CAP) – Emergency management in children [PDF 440.59 KB] |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (more than 1 month of age) [PDF 724.18 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (unable to tolerate oral antibiotics) [PDF 724.18 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01066 - Empyema [PDF 563.28 KB] – PICU |
Respiratory infections | CHQ-GDL-01082 - Management of pleural empyema in previously well children guideline [PDF 673.89 KB] |
Respiratory infections | CHQ-GDL-01202 - Empyema [PDF 724.18 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01066 - Severe community acquired pneumonia (severe CAP) [PDF 563.28 KB] – PICU |
Respiratory infections | CHQ-GDL-01066 - Nosocomial or ventilator associated pneumonia [PDF 563.28 KB] – PICU |
Respiratory infections | CHQ-GDL-01202 - Pertussis [PDF 724.18 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01066 - Pertussis [PDF 563.28 KB] – PICU |
Respiratory infections | The Queensland Paediatric Respiratory Syncytial Virus Prevention Program - Nirsevimab |
Respiratory infections | CHQ-GDL-01202 - Tracheitis [PDF 724.18 KB] |
Respiratory infections | CHQ-GDL-01202 - Epiglottitis [PDF 724.18 KB] |
Respiratory infections | CHQ-GDL-60004 - Croup [PDF 855.55 KB] |
Respiratory infections | CHQ-GDL-01073 - Cystic fibrosis – Empirical antibiotic management [PDF 613.07 KB] |
Respiratory infections | Non-tuberculous mycobacterium treatment – NTM cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | MRSA pulmonary eradication – Cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | Pseudomonas aeruginosa pulmonary eradication – cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | Burkholderia cepacia (B.cepacia) – cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | Allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis – empirical antifungal management [PDF 613.07 KB] |
Respiratory infections | CHQ-GDL-01072 - Empirical antimicrobial therapy for children with non cystic fibrosis bronchiectasis [PDF 458.54 KB] |
Respiratory infections | Pseudomonas aeruginosa pulmonary eradication – non cystic fibrosis bronchiectasis [PDF 458.54 KB] |
Respiratory infections | Azithromycin as anti-inflammatory (non cystic fibrosis bronchiectasis or CSLD) [PDF 458.54 KB] |
Respiratory infections | Treatment of tuberculosis in children and adults on the Queensland Health website |
Respiratory infections | Treatment of tuberculosis in pregnant women and newborn infants on the Queensland Health website |
Respiratory infections | Translated tuberculosis fact sheets for patients on the Queensland Health website |
Respiratory infections | CHQ-GDL-01071 - Respiratory syncytial virus (RSV) prophylaxis – Palivizumab for Queensland Health staff on the intranet |
Respiratory infections | CHQ-GDL-600013 - Drowning – Emergency management guideline |
Sepsis | Statewide paediatric sepsis pathway on Clinical Excellence Queensland website |
Sepsis | CHQ-GDL-70044 - Sickle cell crisis – Emergency management in children guideline
[PDF 368.57 KB] |
Sepsis | CHQ-GDL-01202 - Community acquired sepsis (less than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
Sepsis | CHQ-GDL-01202 - Community acquired sepsis (more than 2 months of age) [PDF 724.18 KB] – ED and inpatient wards |
Sepsis | CHQ-GDL-01066 - Community acquired sepsis [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01066 - Nosocomial sepsis (including CVL sepsis) [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01066 - Sepsis in immunocompromised host with febrile neutropenia [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01066 - Toxic Shock Syndrome [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01249 - Febrile neutropenia – acute and ongoing management for oncology and haematology [PDF 622.23 KB] |
Sepsis | CHQ-GDL-01249 - Febrile non-neutropenia – oncology [PDF 622.23 KB] |
Sepsis | Teicoplanin prophylaxis against streptococcus mitis (and VGS) health care associated blood stream infections (HA BSI) in highly at risk children with cancer [PDF 622.23 KB] |
Sepsis | CHQ-PROC-03455 – Management of compromised or fractured Central Venous Access Device (CVAD) [PDF 304.16 KB] |
Sepsis | CHQ-GDL-01069 - Fever in a child with central venous catheter guideline – CVL, CVAD, PORT and PICC [PDF 647.24 KB] |
Sepsis | CHQ-GDL-01065 - Antibiotic lock therapy for catheter related blood stream infections – CVL, CVAD and PORT [PDF 275.66 KB] |
Sepsis | CHQ-GDL-01060 - Taurolidine or citrate lock (taurolock) guideline – CLABSI prevention for CVL, CVAD and PORT for Queensland health staff on the intranet |
Sepsis | CHQ-PROC-01052 - Parenteral nutrition, emergency management of the child undergoing home parenteral nutrition [PDF 312.6 KB] |
Sepsis | CHQ-GDL-60819 – Invasive pneumococcal disease : Assessment and initial investigation to exclude immune deficiency guideline for Queensland Health staff on the intranet |
Skeletal, soft tissue and skin infections | CHQ-GDL-01066 - Severe cellulitis [PDF 563.28 KB] – PICU |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Severe preseptal cellulitis [PDF 724.18 KB] – inpatients |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Antibiotic prophylaxis for wounds (excluding fractures, wounds sustained in water and animal bites) [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Moderate to severe peri-orbital cellulitis (more than 5 years old and HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Septic arthritis (more than 5 years old and HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Osteomyelitis (more than 5 years old and HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Peri-orbital cellulitis (less than 5 years old and not HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Septic arthritis (less than 5 years old and not HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Osteomyelitis (less than 5 years old and not HIB immune) [PDF 724.18 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Orbital cellulitis [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Compound fractures [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Cellulitis – outpatients [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Severe cervical lymphadenitis – inpatients [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Cervical lymphadenitis – outpatients [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Impetigo – outpatient [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01063 - Recurrent boils (furunculosis) and staphylococcal decolonisation for MSSA and MRSA [PDF 361.1 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Animal bites (dog bites) or wounds [PDF 724.18 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01023 - Tetanus prophylaxis in wound management [PDF 572.8 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-63000 - Water related wound infections [PDF 181.31 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01066 - Necrotising fasciitis [PDF 563.28 KB] – PICU |
Skeletal, soft tissue and skin infections | CHQ-GDL-01067 - Paediatric bone and Joint infection management [PDF 269.79 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-00723 - Peri-orbital and orbital cellulitis – emergency management in children guideline [PDF 530.08 KB] |
Urinary tract infections (UTI) | CHQ-GDL-01066 - Urinary tract infections and pyelonephritis [PDF 563.28 KB] – PICU |
Urinary tract infections (UTI) | CHQ-GDL-01202 - Urinary tract infections and pyelonephritis [PDF 724.18 KB] – ED and inpatient wards |
Fungal infections | CHQ-GDL-01075 – Antifungal prophylaxis and treatment in paediatric oncology patients and other immunocompromised children
[PDF 795.38 KB] |
IV to oral switch | CHQ-GDL-01057 - Antimicrobial treatment: Early Intravenous (IV) to oral switch paediatric guideline [PDF 606.1 KB] |
Human Immunodeficiency Virus (HIV) and Hepatitis B | CHQ-GDL-65664 - Post exposure prophylaxis for HIV [PDF 283.58 KB] |
Human Immunodeficiency Virus (HIV) and Hepatitis B | CHQ-GDL-65665 - Community acquired needle stick injury [PDF 483.38 KB] |
Human Immunodeficiency Virus (HIV) | CHQ-GDL-01243 - Management of newborns born to women with Human Immunodeficiency Virus (HIV) [PDF 563.01 KB] |
Human Immunodeficiency Virus (HIV) | Antiretroviral and HIV drug dosing for children and adolescents 2022 – 2023 guideline from the Imperial College Healthcare NHS Trust on the Children's HIV Association website |
Human Immunodeficiency Virus (HIV) | Guidelines for the use of antiretroviral agents in paediatric HIV infection on the Clinical Info HIV website |
Human Immunodeficiency Virus (HIV) | UK HIV guidelines on the Children's HIV Association website |
Human Immunodeficiency Virus (HIV) | HIV drug interactions checker tool on the University of Liverpool website |
Human Immunodeficiency Virus (HIV) | HIV drug resistance database on the Stanford University website |
Human Immunodeficiency Virus (HIV) | Post-exposure prophylaxis (PEP) for HIV guidelines on the ASHM website |
Hepatitis B and C | CHQ-GDL-04794 - Treatment and Management of Viral Hepatitis (B and C). A Multidisciplinary Team Approach for Queensland Health staff on the intranet |
Hepatitis C | Hepatitis C virus (HCV) in children: Australian Commentary on AASLD-IDSA guidance on the ASHM website |
Immunisations and vaccines | Asplenia and hyposplenism paediatric Guidelines for 0 to 18 years on the Spleen Australia website |
Immunisations and vaccines | Immunisation schedules on the Queensland Health website |
Immunisations and vaccines | CHQ-GDL-01221 - Immunisation guideline for medically at risk children guideline for Queensland Health staff on the intranet |
Therapeutic drug monitoring (TDM) | CHQ-PMG-01293 - Paediatric vancomycin therapeutic drug monitoring [PDF 343.32 KB] |
Therapeutic drug monitoring (TDM) | CHQ-PMG-01294 - Paediatric tobramycin and gentamicin therapeutic drug monitoring [PDF 368.53 KB] |
Zoonotic infection | CHQ-GDL-00719 - Children presenting with potential lyssavirus (rabies) exposure – Emergency management in children [PDF 276.21 KB] |
Tropical infections | CHQ-PROC-01056 - Assessment and management of malaria in children [PDF 286.34 KB] |
Travel medicine | Assessing fever in the returned traveller on the Australian Prescriber website |
Dental infections | CHQ-GDL-00758 - Periapical abscess [PDF 1522.35 KB] |
Dental infections | CHQ-GDL-00758 - Periodontal abscess [PDF 1522.35 KB] |
Dental infections | CHQ-GDL-00758 - Pericoronitis [PDF 1522.35 KB] |
Dental infections | CHQ-GDL-00758 - Facial cellulitis of dental origin [PDF 1522.35 KB] |
Dental infections | CHQ-GDL-00758 - Alveolar osteitis [PDF 1522.35 KB] |
Dental infections | CHQ-GDL-00758 - Avulsion [PDF 1522.35 KB] |
Specialty guidelines | CHQ-GDL-01202 - Paediatric Antibiocard: Empirical Antibiotic Guidelines [PDF 724.18 KB] |
Surgical antibiotic prophylaxis | Eradication of S. aureus nasal colonisation in cardiac surgery patients [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | ENT surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Adenotonsillectomy and grommet insertion – no prophylaxis required [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cochlear implantation – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Laryngeal reconstruction – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cranial vault remodelling – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Craniosynostosis surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Head, neck or thoracic surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Neurosurgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Orthopaedic surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cardiac surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | ECMO cannulation and decannulation – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cardiac surgery and chest exploration – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cardiac – chest re-cannulation, exploration and closure [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Cardiac – postoperative open chest [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Abdominal surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Colorectal surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Appendicectomy – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Upper gastro-intestinal tract (GIT) surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Biliary surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Endoscopic procedures – no prophylaxis required [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Colonoscopic procedures – no prophylaxis required [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Kasai procedure – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Biliary reconstructive surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Gastro-intestinal anastomosis (performed without bowel prep) – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Liver transplant – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Renal transplant – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Percutaneous transhepatic cholangiogram – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Percutaneous endoscopic gastrostomy (PEG) placement – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Jejunostomy (PEJ) placement – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Nephrostomy tube placement – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Interventional radiology – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Tenckhoff peritoneal dialysis catheter insertion – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Urinary tract surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Micturating cystourethrogram (MCUG) – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Hypospadias surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Amputations – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Burns and surgical debridement – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Endocarditis surgery – prophylaxis [PDF 601.18 KB] |
Surgical antibiotic prophylaxis | Mupirocin 2% (Bactroban) nasal ointment to prevent surgical site infection and staphylococcus aureus colonisation [PDF 601.18 KB] – Information for paediatric cardiac surgery patients and families |
Meningococcal bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Pneumococcal bacteraemia (without meningitis) (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Streptococcus pyogenes (Group A Streptococcus) bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Group B Streptococcus bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Staphylococcus aureus bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Gram-negative bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
CVC (CVL/CLABSI)-associated bacteraemia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Bacterial meningitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Brain abscess and subdural empyema (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
VP shunt infections (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Peritonsillar abscess(directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Retropharyngeal abscess (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Mastoiditis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Acute bacterial sinusitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Acute cervical lymphadenitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Community-acquired pneumonia (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Acute osteomyelitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Chronic osteomyelitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Septic arthritis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Pyomyositis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Cellulitis/skin abscesses or boils/surgical site infection (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Preseptal (periorbital) cellulitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Orbital cellulitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Lower urinary tract infection (UTI/ cystitis) (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Pyelonephritis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Epididymitis (directed treatment and timing of switch) | CHQ-GDL-01057 - Antimicrobial treatment: Antibiotic duration and timing of the switch from intravenous to oral for common bacterial infections in children [PDF 606.1 KB] |
Primary sclerosing cholangitis in Ulcerative colitis | CHQ-GDL-00263 - Use of Oral Vancomycin in Children with Primary Sclerosing Cholangitis for Queensland Health staff on the intranet |
Viral infections in immunocompromised host | Cytomegalovirus (CMV) - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
Viral infections in immunocompromised host | Adenovirus - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
Viral infections in immunocompromised host | Epstein Barr virus (EBV) - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
Viral infections in immunocompromised host | Herpes simplex virus (HSV) - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
Viral infections in immunocompromised host | Varicella zoster virus (VZV) - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
Viral infections in immunocompromised host | Human Herpes virus 6 (HHV6) - CHQ-GDL-02219 Antiviral Prophylaxis and Treatment in Haematopoietic Stem Cell Transplant and Immunocompromised children |
